Latest Commercial Sales News

Sparc Technologies launches a $2.5 million capital raise via a Share Purchase Plan and placement to fast-track commercial rollout of its graphene additive ecosparc® and support green hydrogen scale-up.

Memphasys has cleared a key regulatory hurdle in Vietnam for its Felix™ System, prompting a significant first commercial cartridge order and marking early clinical success in a fast-growing fertility market.

ReNerve Ltd (ASX:RNV) reported an 80% year-on-year revenue increase in Q4 FY26, backed by expanding product lines and a $5 million funding facility. The company is advancing FDA approvals and growing its global distribution footprint, targeting a rapidly expanding $6.19 billion nerve repair biomaterials market.

Memphasys secures exclusive Felix™ commercialisation agreement in Poland, marking its third European market entry with a two-year contract valued at approximately A$350,000.

Eden Innovations reported strong EdenCrete® trial results in India and North America, strategic hires for EdenShield® in defence markets, and completed a $4.05 million placement, ending the quarter debt-free with $5.2 million cash.

Rhythm Biosciences bolstered its financial position with a $5.2 million option underwriting while accelerating commercial adoption of its ColoSTAT® colorectal cancer test and advancing geneType™ partnerships internationally in Q4 FY26.

Epiminder has leveraged its $125 million IPO to advance clinical enrolments, boost Medicare reimbursement, and develop its next-generation Minder device, positioning for a commercial launch in early 2028.

OMG Group delivered a near 50% jump in FY26 net sales, expanding its product range nationally and breaking into international markets with new distribution agreements.

Viva Energy’s 1H26 EBITDA surged to an estimated $770-$780 million, more than doubling from 1H25, driven by elevated refining margins amid Middle East supply disruptions and robust retail and commercial sales.

Green360 Technologies has secured its first binding commercial supply agreement with Holcim Australia for up to 4,800 tonnes of its proprietary MKX-CC low-carbon cement replacement, marking a significant step from development to commercial sales amid tightening supplementary cementitious material supplies.

Li-S Energy marked key commercial and regulatory milestones in Q2 2026, including ISO 9001:2015 certification for its lithium foil line, first commercial foil sale, and US air transport approvals for lithium-sulfur cells. The company also completed a major Battery Testing Centre expansion and began deep-ocean cell testing with MSubs.

Syrah Resources moderated graphite output amid subdued ex-China demand, raised US$72 million to support ramp-up, and advanced Vidalia anode material towards commercial sales in H2 2026.